Subscribe

IDEAS / Tickers

PNTG

The Pennant Group

Verona Pharma’s Breakout Stood Out in a Weak Market

Patrick Dunuwila and Alfonso DePablos favored Verona’s relative strength on September 10, 2024, while separating bullish momentum from warning signs in Pennant, Check Point and Twist.

Recorded Stock Market TV Editorial

Search ideas